30.15MINR
Type
Common Stock
Exchange
BSE
Currency Code
INR
Currency Name
Indian Rupee
Country Name
India
Country ISO
IN
ISIN
INE486F01012
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
16.11
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.18
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
395,620,000
Gross Profit TTM
395,620,000
EBITDA
91,885,000
Profit Margin
-2.71%
Return On Assets TTM
1.17%
Return On Equity TTM
-1.12%
Revenue Per Share TTM
6.642
Qtly Revenue Growth YOY
-21.10%
Diluted Eps TTM
-0.18
Qtly Earnings Growth YOY
14.30%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.1888
Price Book MRQ
2.9982
Enterprise Value Revenue
6
Enterprise Value EBITDA
28
1112.10
2.56%1112.20
2.44%4514.10
1.28%4514.15
1.27%1433.10
1.23%2357.80
0.76%2356.55
0.73%1867.80
0.23%6743.15
-0.62%6747.00
-0.60%